{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:40:14Z","timestamp":1793418014519,"version":"4.5.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.2119\/molmed.2009.00153","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T13:50:35Z","timestamp":1294408235000},"page":"113-125","source":"Crossref","is-referenced-by-count":1266,"title":["Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies"],"prefix":"10.1186","volume":"17","author":[{"given":"Gerd G.","family":"Gauglitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans C.","family":"Korting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Pavicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Jeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,5]]},"reference":[{"key":"1701113_CR1","first-page":"1","volume-title":"New Developments in Wound Care","author":"B Sund","year":"2000","unstructured":"Sund B. (2000) New Developments in Wound Care. PJB Publications, London, pp. 1\u2013255."},{"key":"1701113_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0190-9622(95)90035-7","volume":"33","author":"B Berman","year":"1995","unstructured":"Berman B, Bieley HC. (1995) Keloids. J. Am. Acad. Dermatol. 33:117\u201323.","journal-title":"J. Am. Acad. Dermatol"},{"key":"1701113_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00007611-197007000-00002","volume":"63","author":"EE Peacock Jr","year":"1970","unstructured":"Peacock EE Jr, Madden JW, Trier WC. (1970) Biologic basis for the treatment of keloids and hypertrophic scars. South. Med. J. 63:755\u201360.","journal-title":"South. Med. J"},{"key":"1701113_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/jid.1962.29","volume":"38","author":"RE Mancini","year":"1962","unstructured":"Mancini RE, Quaife JV. (1962) Histogenesis of experimentally produced keloids. J. Invest. Dermatol. 38:143\u201381.","journal-title":"J. Invest. Dermatol"},{"key":"1701113_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00266-006-0253-y","volume":"31","author":"BS Atiyeh","year":"2007","unstructured":"Atiyeh BS. (2007) Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic. Plast. Surg. 31:468\u201394.","journal-title":"Aesthetic. Plast. Surg"},{"key":"1701113_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.mop.0000236389.41462.ef","volume":"18","author":"AE Slemp","year":"2006","unstructured":"Slemp AE, Kirschner RE. (2006) Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr. Opin. Pediatr. 18:396\u2013402.","journal-title":"Curr. Opin. Pediatr"},{"key":"1701113_CR7","first-page":"900","volume-title":"Cutaneous Medicine and Surgery","author":"RG Wheeland","year":"1996","unstructured":"Wheeland RG. (1996) Keloids and hypertrphic scars. In: Cutaneous Medicine and Surgery. Arndt KA, Robinson JK, Leboit PE, Wintroub BU (eds.). Saunders Elsevier, Philadelphia, pp. 900\u20135."},{"key":"1701113_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/00000637-199710000-00014","volume":"39","author":"TS Alster","year":"1997","unstructured":"Alster TS, West TB. (1997) Treatment of scars: a review. Ann. Plast. Surg. 39:418\u201332.","journal-title":"Ann. Plast. Surg"},{"key":"1701113_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/B978-1-4160-3274-8.50051-9","volume-title":"Total Burn Care","author":"HK Hawkins","year":"2007","unstructured":"Hawkins HK. (2007) Pathophysiology of the burn scar. In: Total Burn Care. Herndon DN (ed.) Saunders Elsevier, Philadelphia, pp. 608\u201319."},{"key":"1701113_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0738-081X(94)90254-2","volume":"12","author":"JC Murray","year":"1994","unstructured":"Murray JC. (1994) Keloids and hypertrophic scars. Clin. Dermatol. 12:27\u201337.","journal-title":"Clin. Dermatol"},{"key":"1701113_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.prs.0000195073.73580.46","volume":"117","author":"A Al-Attar","year":"2006","unstructured":"Al-Attar A, et al. (2006) Keloid pathogenesis and treatment. Plast. Reconstr. Surg. 117:286\u2013300.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR12","first-page":"1198","volume-title":"Dermatology in General Medicine","author":"L From","year":"1993","unstructured":"From L, Assad D. (1993) Neoplasms, pseudoneoplasms, and hyperplasia of supporting tissue origin. In: Dermatology in General Medicine. Jeffers JD, Englis MR (eds.). McGraw-Hill, New York, pp. 1198\u201399."},{"key":"1701113_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0007-1226(90)90046-3","volume":"43","author":"IF Muir","year":"1990","unstructured":"Muir IF. (1990) On the nature of keloid and hypertrophic scars. Br. J. Plast. Surg. 43:61\u20139.","journal-title":"Br. J. Plast. Surg"},{"key":"1701113_CR14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1097\/00006534-199910000-00031","volume":"104","author":"FB Niessen","year":"1999","unstructured":"Niessen FB, Spauwen PH, Schalkwijk J, Kon M. (1999) On the nature of hypertrophic scars and keloids: a review. Plast. Reconstr. Surg. 104:1435\u201358.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/archfaci.8.6.362","volume":"8","author":"D Leventhal","year":"2006","unstructured":"Leventhal D, Furr M, Reiter D. (2006) Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch. Facial. Plast. Surg. 8:362\u20138.","journal-title":"Arch. Facial. Plast. Surg"},{"key":"1701113_CR16","first-page":"84","volume-title":"Rubin\u2019s Pathology","author":"GC Sephel","year":"2001","unstructured":"Sephel GC, Woodward SC. (2001) Repair, regeneration, and fibrosis. In: Rubin\u2019s Pathology. Rubin E (ed.). Lippincott, Williams & Wilkins, Baltimore, pp. 84\u2013117."},{"key":"1701113_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0094-1298(20)32271-9","volume":"1","author":"JO Oluwasanmi","year":"1974","unstructured":"Oluwasanmi JO. (1974) Keloids in the African. Clin. Plast. Surg. 1:179\u201395.","journal-title":"Clin. Plast. Surg"},{"key":"1701113_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00006534-197510000-00019","volume":"56","author":"MF Moustafa","year":"1975","unstructured":"Moustafa MF, Abdel-Fattah MA, Abdel-Fattah DC. (1975) Presumptive evidence of the effect of pregnancy estrogens on keloid growth: case report. Plast. Reconstr. Surg. 56:450\u20133.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/00005373-198310000-00009","volume":"23","author":"EA Deitch","year":"1983","unstructured":"Deitch EA, et al. (1983) Hypertrophic burn scars: analysis of variables. J. Trauma. 23:895\u20138.","journal-title":"J. Trauma"},{"key":"1701113_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/0305-4179(90)90033-S","volume":"16","author":"WH Lewis","year":"1990","unstructured":"Lewis WH, Sun KK. (1990) Hypertrophic scar: a genetic hypothesis. Burns. 16:176\u20138.","journal-title":"Burns"},{"key":"1701113_CR21","first-page":"500","volume-title":"Woundhealing, Biochemical and Clinical Aspects","author":"CJ Murray","year":"1992","unstructured":"Murray CJ, Pinnel SR. (1992) Keloids and excessive dermal scarring. In: Woundhealing, Biochemical and Clinical Aspects. Cohen IK, Diegelmann RF, Lindblad WJ (eds.). Saunders Elsevier, Philadelphia, pp. 500\u20139."},{"key":"1701113_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bjps.2004.04.024","volume":"58","author":"A Bayat","year":"2005","unstructured":"Bayat A, et al. (2005) Keloid disease: clinical relevance of single versus multiple site scars. Br. J. Plast. Surg. 58:28\u201337.","journal-title":"Br. J. Plast. Surg"},{"key":"1701113_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.0022-202X.2004.22327.x","volume":"122","author":"AG Marneros","year":"2004","unstructured":"Marneros AG, et al. (2004) Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J. Invest. Dermatol. 122:1126\u201332.","journal-title":"J. Invest. Dermatol"},{"key":"1701113_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1744-313X.2008.00780.x","volume":"35","author":"JJ Brown","year":"2008","unstructured":"Brown JJ, Ollier WE, Thomson W, Bayat A. (2008) Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int. J. Immunogenet. 35:303\u20137.","journal-title":"Int. J. Immunogenet"},{"key":"1701113_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1524-4725.1983.tb00851.x","volume":"9","author":"LC Ford","year":"1983","unstructured":"Ford LC, King DF, Lagasse LD, Newcomer V. (1983) Increased androgen binding in keloids: a preliminary communication. J. Dermatol. Surg. Oncol. 9:545\u20137.","journal-title":"J. Dermatol. Surg. Oncol"},{"key":"1701113_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/00006534-199708000-00017","volume":"100","author":"HP Schierle","year":"1997","unstructured":"Schierle HP, Scholz D, Lemperle G. (1997) Elevated levels of testosterone receptors in keloid tissue: an experimental investigation. Plast. Reconstr. Surg. 100:390\u20136.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR27","first-page":"185","volume":"175","author":"OJ Placik","year":"1992","unstructured":"Placik OJ, Lewis VL Jr. (1992) Immunologic associations of keloids. Surg. Gynecol. Obstet. 175:185\u201393.","journal-title":"Surg. Gynecol. Obstet"},{"key":"1701113_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00004630-198703000-00008","volume":"8","author":"CJ Smith","year":"1987","unstructured":"Smith CJ, Smith JC, Finn MC. (1987) The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring. J. Burn Care Rehabil. 8:126\u201331.","journal-title":"J. Burn Care Rehabil"},{"key":"1701113_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00006534-197403000-00004","volume":"53","author":"KM Ramakrishnan","year":"1974","unstructured":"Ramakrishnan KM, Thomas KP, Sundararajan CR. (1974) Study of 1,000 patients with keloids in South India. Plast. Reconstr. Surg. 53:276\u201380.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR30","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0039-6109(05)70576-4","volume":"77","author":"EE Tredget","year":"1997","unstructured":"Tredget EE, Nedelec B, Scott PG, Ghahary A. (1997) Hypertrophic scars, keloids, and contractures: the cellular and molecular basis for therapy. Surg. Clin. North Am. 77:701\u201330.","journal-title":"Surg. Clin. North Am"},{"key":"1701113_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1365-2133.2009.09258.x","volume":"161","author":"JJ Brown","year":"2009","unstructured":"Brown JJ, Bayat A. (2009) Genetic susceptibility to raised dermal scarring. Br. J. Dermatol. 161:8\u201318.","journal-title":"Br. J. Dermatol"},{"issue":"Suppl1","key":"1701113_CR32","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1111\/j.1524-475X.2007.00219.x","volume":"15","author":"A Armour","year":"2007","unstructured":"Armour A, Scott PG, Tredget EE. (2007) Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen. 15 Suppl 1:S6\u201317.","journal-title":"Wound Repair Regen"},{"key":"1701113_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA. (2004) Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat. Rev. Immunol. 4:583\u201394.","journal-title":"Nat. Rev. Immunol"},{"key":"1701113_CR34","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1172\/JCI741","volume":"101","author":"C Doucet","year":"1998","unstructured":"Doucet C, et al. (1998) Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 101:2129\u201339.","journal-title":"J. Clin. Invest"},{"key":"1701113_CR35","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1378\/chest.124.4.1187","volume":"124","author":"DW Kamp","year":"2003","unstructured":"Kamp DW. (2003) Idiopathic pulmonary fibrosis: the inflammation hypothesis revisited. Chest. 124:1187\u201390.","journal-title":"Chest"},{"key":"1701113_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cps.2009.05.014","volume":"36","author":"A Ladak","year":"2009","unstructured":"Ladak A, Tredget EE. (2009) Pathophysiology and management of the burn scar. Clin. Plast. Surg. 36:661\u201374.","journal-title":"Clin. Plast. Surg"},{"key":"1701113_CR37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jamcollsurg.2007.12.001","volume":"206","author":"PD Butler","year":"2008","unstructured":"Butler PD, Longaker MT, Yang GP. (2008) Current progress in keloid research and treatment. J. Am. Coll. Surg. 206:731\u201341.","journal-title":"J. Am. Coll. Surg"},{"key":"1701113_CR38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1046\/j.1523-1747.2000.00180.x","volume":"115","author":"H Ishihara","year":"2000","unstructured":"Ishihara H, et al. (2000) Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor. J. Invest. Dermatol. 115:1065\u201371.","journal-title":"J. Invest. Dermatol"},{"key":"1701113_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1357-4310(97)80541-2","volume":"4","author":"TL Tuan","year":"1998","unstructured":"Tuan TL, Nichter LS. (1998) The molecular basis of keloid and hypertrophic scar formation. Mol. Med. Today. 4:19\u201324.","journal-title":"Mol. Med. Today"},{"key":"1701113_CR40","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/sj.jid.5701149","volume":"128","author":"JC Smith","year":"2008","unstructured":"Smith JC, et al. (2008) Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J. Invest. Dermatol. 128:1298\u2013310.","journal-title":"J. Invest. Dermatol"},{"key":"1701113_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00268-002-6737-2","volume":"27","author":"KM Bullard","year":"2003","unstructured":"Bullard KM, Longaker MT, Lorenz HP. (2003) Fetal wound healing: current biology. World J. Surg. 27:54\u201361.","journal-title":"World J. Surg"},{"key":"1701113_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1046\/j.0022-202x.2001.01680.x","volume":"118","author":"G Szulgit","year":"2002","unstructured":"Szulgit G, et al. (2002) Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars. J. Invest. Dermatol. 118:409\u201315.","journal-title":"J. Invest. Dermatol"},{"key":"1701113_CR43","first-page":"336","volume":"34","author":"O Kose","year":"2008","unstructured":"Kose O, Waseem A. (2008) Keloids and hypertrophic scars: are they two different sides of the same coin? Dermatol. Surg. 34:336\u201346.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR44","first-page":"216","volume":"85","author":"O Bock","year":"2005","unstructured":"Bock O, et al. (2005) Studies of transforming growth factors beta 1\u20133 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta. Derm. Venereol. 85:216\u201320.","journal-title":"Acta. Derm. Venereol"},{"key":"1701113_CR45","first-page":"485","volume":"152","author":"P Schmid","year":"1998","unstructured":"Schmid P, et al. (1998) Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am. J. Pathol. 152:485\u201393.","journal-title":"Am. J. Pathol"},{"key":"1701113_CR46","first-page":"179","volume":"43","author":"TY Lee","year":"1999","unstructured":"Lee TY, et al. (1999) Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann. Plast. Surg. 43:179\u201384.","journal-title":"Ann. Plast. Surg"},{"key":"1701113_CR47","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1067-1927.2004.012507.x","volume":"12","author":"W Xia","year":"2004","unstructured":"Xia W, et al. (2004) Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells. Wound Repair Regen. 12:546\u201356.","journal-title":"Wound Repair Regen"},{"key":"1701113_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jamcollsurg.2005.03.032","volume":"201","author":"L Lu","year":"2005","unstructured":"Lu L, et al. (2005) The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J. Am. Coll. Surg. 201:391\u20137.","journal-title":"J. Am. Coll. Surg"},{"key":"1701113_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.gt.3301865","volume":"10","author":"MF Cordeiro","year":"2003","unstructured":"Cordeiro MF, et al. (2003) Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther. 10:59\u201371.","journal-title":"Gene Ther"},{"key":"1701113_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0140-6736(92)90009-R","volume":"339","author":"M Shah","year":"1992","unstructured":"Shah M, Foreman DM, Ferguson MW. (1992) Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet. 339:213\u20134.","journal-title":"Lancet"},{"issue":"Pt3","key":"1701113_CR51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1242\/jcs.108.3.985","volume":"108","author":"M Shah","year":"1995","unstructured":"Shah M, Foreman DM, Ferguson MW. (1995) Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell. Sci. 108(Pt 3):985\u20131002.","journal-title":"J. Cell. Sci"},{"issue":"Suppl1","key":"1701113_CR52","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1111\/j.1524-475X.2007.00226.x","volume":"15","author":"KR Cutroneo","year":"2007","unstructured":"Cutroneo KR. (2007) TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen. 15 Suppl 1: S54\u201360.","journal-title":"Wound Repair Regen"},{"key":"1701113_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tibs.2004.03.008","volume":"29","author":"P Dijke ten","year":"2004","unstructured":"ten Dijke P, Hill CS. (2004) New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29:265\u201373.","journal-title":"Trends Biochem. Sci"},{"key":"1701113_CR54","doi-asserted-by":"publisher","first-page":"21570","DOI":"10.1074\/jbc.M502071200","volume":"280","author":"J Kopp","year":"2005","unstructured":"Kopp J, et al. (2005) Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J. Biol. Chem. 280:21570\u20136.","journal-title":"J. Biol. Chem"},{"key":"1701113_CR55","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.bjps.2006.05.007","volume":"60","author":"Z Wang","year":"2007","unstructured":"Wang Z, et al. (2007) Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J. Plast. Reconstr. Aesthet. Surg. 60:1193\u20139.","journal-title":"J. Plast. Reconstr. Aesthet. Surg"},{"key":"1701113_CR56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/39369","volume":"389","author":"A Nakao","year":"1997","unstructured":"Nakao A, et al. (1997) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 389:631\u20135.","journal-title":"Nature"},{"key":"1701113_CR57","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0016-5085(03)00666-8","volume":"125","author":"S Dooley","year":"2003","unstructured":"Dooley S, et al. (2003) Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology. 125:178\u201391.","journal-title":"Gastroenterology"},{"key":"1701113_CR58","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/01.moo.0000170525.74264.f8","volume":"13","author":"MA Chen","year":"2005","unstructured":"Chen MA, Davidson TM. (2005) Scar management: prevention and treatment strategies. Curr. Opin. Otolaryngol. Head Neck Surg. 13:242\u20137.","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg"},{"key":"1701113_CR59","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1046\/j.1523-1755.2002.0610s1094.x","volume":"61","author":"Y Terada","year":"2002","unstructured":"Terada Y, et al. (2002) Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney. Kidney Int. 61: S94\u20138.","journal-title":"Kidney Int"},{"key":"1701113_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/path.1502","volume":"202","author":"FB Niessen","year":"2004","unstructured":"Niessen FB, Schalkwijk J, Vos H, Timens W. (2004) Hypertrophic scar formation is associated with an increased number of epidermal Langerhans cells. J. Pathol. 202:121\u20139.","journal-title":"J. Pathol"},{"key":"1701113_CR61","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<192::AID-PATH163>3.0.CO;2-X","volume":"186","author":"MP Andriessen","year":"1998","unstructured":"Andriessen MP, Niessen FB, Van de Kerkhof PC, Schalkwijk J. (1998) Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study. J. Pathol. 186:192\u2013200.","journal-title":"J. Pathol"},{"key":"1701113_CR62","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/00006534-200103000-00022","volume":"107","author":"IJ Lim","year":"2001","unstructured":"Lim IJ, et al. (2001) Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast. Reconstr. Surg. 107:797\u2013808.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.jid.5700701","volume":"127","author":"SA Eming","year":"2007","unstructured":"Eming SA, Krieg T, Davidson JM. (2007) Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127:514\u201325.","journal-title":"J. Invest. Dermatol"},{"key":"1701113_CR64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1067-1927.2004.012310.x","volume":"12","author":"KE Moyer","year":"2004","unstructured":"Moyer KE, Saggers GC, Ehrlich HP. (2004) Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication. Wound Repair. Regen. 12:269\u201375.","journal-title":"Wound Repair. Regen"},{"key":"1701113_CR65","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.0959-4493.2001.00272.x","volume":"12","author":"C Noli","year":"2001","unstructured":"Noli C, Miolo A. (2001) The mast cell in wound healing. Vet. Dermatol. 12:303\u201313.","journal-title":"Vet. Dermatol"},{"key":"1701113_CR66","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1111\/j.1524-475X.2007.00225.x","volume":"1","author":"A Ghahary","year":"2007","unstructured":"Ghahary A, Ghaffari A. (2007) Role of keratinocyte-fibroblast cross-talk in development of hyper-trophic scar. Wound Repair Regen. 15 Suppl 1: S46\u201353.","journal-title":"Wound Repair Regen. 15 Suppl"},{"key":"1701113_CR67","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/1523-1747.ep12343658","volume":"106","author":"A Ghahary","year":"1996","unstructured":"Ghahary A, et al. (1996) Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J. Invest. Dermatol. 106:476\u201381.","journal-title":"J. Invest. Dermatol"},{"key":"1701113_CR68","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/10454411930040020401","volume":"4","author":"H Birkedal-Hansen","year":"1993","unstructured":"Birkedal-Hansen H, et al. (1993) Matrix metalloproteinases: a review. Crit. Rev. Oral. Biol. Med. 4:197\u2013250.","journal-title":"Crit. Rev. Oral. Biol. Med"},{"key":"1701113_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1749-6632.1988.tb18803.x","volume":"548","author":"B Johnson-Wint","year":"1988","unstructured":"Johnson-Wint B. (1988) Do keratinocytes regulate fibroblast collagenase activities during morphogenesis? Ann. N. Y. Acad. Sci. 548:167\u201373.","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"1701113_CR70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2133.2005.06698.x","volume":"153","author":"M Fujiwara","year":"2005","unstructured":"Fujiwara M, Muragaki Y, Ooshima A. (2005) Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br. J. Dermatol. 153:295\u2013300.","journal-title":"Br. J. Dermatol"},{"key":"1701113_CR71","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1524-475X.1999.00166.x","volume":"7","author":"AN Neely","year":"1999","unstructured":"Neely AN, et al. (1999) Gelatinase activity in keloids and hypertrophic scars. Wound Repair Regen. 7:166\u201371.","journal-title":"Wound Repair Regen"},{"key":"1701113_CR72","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/jcb.240530404","volume":"53","author":"A Mauviel","year":"1993","unstructured":"Mauviel A. (1993) Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem. 53:288\u201395.","journal-title":"J. Cell. Biochem"},{"key":"1701113_CR73","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.4049\/jimmunol.161.6.3071","volume":"161","author":"Y Zhang","year":"1998","unstructured":"Zhang Y, McCluskey K, Fujii K, Wahl LM. (1998) Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J. Immunol. 161:3071\u20136.","journal-title":"J. Immunol"},{"key":"1701113_CR74","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood.V100.4.1160.h81602001160_1160_1167","volume":"100","author":"GA McQuibban","year":"2002","unstructured":"McQuibban GA, et al. (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood. 100:1160\u20137.","journal-title":"Blood"},{"key":"1701113_CR75","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.289.5482.1202","volume":"289","author":"GA McQuibban","year":"2000","unstructured":"McQuibban GA, et al. (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science. 289:1202\u20136.","journal-title":"Science"},{"key":"1701113_CR76","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/cs0900417","volume":"90","author":"PG Scott","year":"1996","unstructured":"Scott PG, et al. (1996) Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars. Clin. Sci. (Lond). 90:417\u201325.","journal-title":"Clin. Sci. (Lond)"},{"key":"1701113_CR77","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1046\/j.1365-2559.2000.00824.x","volume":"36","author":"K Sayani","year":"2000","unstructured":"Sayani K, et al. (2000) Delayed appearance of decorin in healing burn scars. Histopathology. 36:262\u201372.","journal-title":"Histopathology"},{"key":"1701113_CR78","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.burns.2008.08.021","volume":"35","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, et al. (2009) Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts. Burns. 35:527\u201337.","journal-title":"Burns"},{"key":"1701113_CR79","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/TA.0b013e3181c4070d","volume":"68","author":"A Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay A, et al. (2010) Syndecan-2 and decorin: proteoglycans with a difference\u2014implications in keloid pathogenesis. J. Trauma. 68:999\u20131008.","journal-title":"J. Trauma"},{"key":"1701113_CR80","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1067\/msy.2001.116453","volume":"130","author":"B Nedelec","year":"2001","unstructured":"Nedelec B, et al. (2001) Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-alpha2b. Surgery. 130:798\u2013808.","journal-title":"Surgery"},{"key":"1701113_CR81","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1097\/PRS.0b013e31816a9f6f","volume":"121","author":"JS Bond","year":"2008","unstructured":"Bond JS, et al. (2008) Maturation of the human scar: an observational study. Plast. Reconstr. Surg. 121:1650\u20138.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR82","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/01.prs.0000299183.88334.37","volume":"121","author":"JS Bond","year":"2008","unstructured":"Bond JS, et al. (2008) Scar redness in humans: how long does it persist after incisional and excisional wounding? Plast. Reconstr. Surg. 121:487\u201396.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR83","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/00006534-200208000-00031","volume":"110","author":"TA Mustoe","year":"2002","unstructured":"Mustoe TA, et al. (2002) International clinical recommendations on scar management. Plast. Reconstr. Surg. 110:560\u201371.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR84","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bjps.2007.05.007","volume":"61","author":"P Durani","year":"2008","unstructured":"Durani P, Bayat A. (2008) Levels of evidence for the treatment of keloid disease. J. Plast. Reconstr. Aesthet. Surg. 61:4\u201317.","journal-title":"J. Plast. Reconstr. Aesthet. Surg"},{"key":"1701113_CR85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0378-6323.13777","volume":"71","author":"S Mutalik","year":"2005","unstructured":"Mutalik S. (2005) Treatment of keloids and hypertrophic scars. Indian J. Dermatol. Venereol. Leprol. 71:3\u20138.","journal-title":"Indian J. Dermatol. Venereol. Leprol"},{"key":"1701113_CR86","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/00005373-197612000-00004","volume":"16","author":"PS Baur","year":"1976","unstructured":"Baur PS, et al. (1976) Ultrastructural analysis of pressure-treated human hypertrophic scars. J. Trauma. 16:958\u201367.","journal-title":"J. Trauma"},{"key":"1701113_CR87","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.burns.2004.06.018","volume":"32","author":"L Macintyre","year":"2006","unstructured":"Macintyre L, Baird M. (2006) Pressure garments for use in the treatment of hypertrophic scars\u2014a review of the problems associated with their use. Burns. 32:10\u20135.","journal-title":"Burns"},{"key":"1701113_CR88","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1396-0296.2004.04022.x","volume":"17","author":"AP Kelly","year":"2004","unstructured":"Kelly AP. (2004) Medical and surgical therapies for keloids. Dermatol. Ther. 17:212\u20138.","journal-title":"Dermatol. Ther"},{"key":"1701113_CR89","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1524-475X.2003.11504.x","volume":"11","author":"F Reno","year":"2003","unstructured":"Reno F, et al. (2003) In vitro mechanical compression induces apoptosis and regulates cytokines release in hypertrophic scars. Wound Repair Regen. 11:331\u20136.","journal-title":"Wound Repair Regen"},{"key":"1701113_CR90","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.burns.2005.04.014","volume":"31","author":"E Kerckhove Van den","year":"2005","unstructured":"Van den Kerckhove E, et al. (2005) The assessment of erythema and thickness on burn related scars during pressure garment therapy as a preventive measure for hypertrophic scarring. Burns. 31:696\u2013702.","journal-title":"Burns"},{"key":"1701113_CR91","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0007-1226(92)90027-U","volume":"45","author":"Y Sawada","year":"1992","unstructured":"Sawada Y, Sone K. (1992) Hydration and occlusion treatment for hypertrophic scars and keloids. Br. J. Plast. Surg. 45:599\u2013603.","journal-title":"Br. J. Plast. Surg"},{"key":"1701113_CR92","first-page":"947","volume":"21","author":"JE Fulton Jr.","year":"1995","unstructured":"Fulton JE, Jr. (1995) Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol. Surg. 21:947\u201351.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR93","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jamcollsurg.2007.11.022","volume":"206","author":"RG Reish","year":"2008","unstructured":"Reish RG, Eriksson E. (2008) Scar treatments: preclinical and clinical studies. J. Am. Coll. Surg. 206:719\u201330.","journal-title":"J. Am. Coll. Surg"},{"key":"1701113_CR94","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jdermsci.2003.08.008","volume":"33","author":"TT Phan","year":"2003","unstructured":"Phan TT, et al. (2003) Quercetin inhibits fibronectin production by keloid-derived fibroblasts. Implication for the treatment of excessive scars. J. Dermatol. Sci. 33:192\u20134.","journal-title":"J. Dermatol. Sci"},{"key":"1701113_CR95","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1524-4725.1999.08240.x","volume":"25","author":"BA Jackson","year":"1999","unstructured":"Jackson BA, Shelton AJ. (1999) Pilot study evaluating topical onion extract as treatment for postsurgical scars. Dermatol. Surg. 25:267\u20139.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR96","first-page":"193","volume":"32","author":"VQ Chung","year":"2006","unstructured":"Chung VQ, Kelley L, Marra D, Jiang SB. (2006) Onion extract gel versus petrolatum emollient on new surgical scars: prospective double-blinded study. Dermatol. Surg. 32:193\u20137.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR97","first-page":"277","volume":"20","author":"J Beuth","year":"2006","unstructured":"Beuth J, et al. (2006) Safety and efficacy of local administration of contractubex to hypertrophic scars in comparison to corticosteroid treatment. Results of a multicenter, comparative epidemiological cohort study in Germany. In Vivo. 20:277\u201383.","journal-title":"In Vivo"},{"key":"1701113_CR98","first-page":"891","volume":"32","author":"WS Ho","year":"2006","unstructured":"Ho WS, Ying SY, Chan PC, Chan HH. (2006) Use of onion extract, heparin, allantoin gel in prevention of scarring in Chinese patients having laser removal of tattoos: a prospective randomized controlled trial. Dermatol. Surg. 32:891\u20136.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR99","first-page":"907","volume":"32","author":"A Asilian","year":"2006","unstructured":"Asilian A, Darougheh A, Shariati F. (2006) New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol. Surg. 32:907\u201315.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR100","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaad.2006.03.022","volume":"55","author":"JM Zurada","year":"2006","unstructured":"Zurada JM, Kriegel D, Davis IC. (2006) Topical treatments for hypertrophic scars. J. Am. Acad. Dermatol. 55:1024\u201331.","journal-title":"J. Am. Acad. Dermatol"},{"key":"1701113_CR101","doi-asserted-by":"publisher","first-page":"S209","DOI":"10.1067\/mjd.2002.126585","volume":"47","author":"B Berman","year":"2002","unstructured":"Berman B, Kaufman J. (2002) Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J. Am. Acad. Dermatol. 47:S209\u201311.","journal-title":"J. Am. Acad. Dermatol"},{"key":"1701113_CR102","first-page":"455","volume":"8","author":"B Berman","year":"2009","unstructured":"Berman B, et al. (2009) Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study. J. Drugs Dermatol. 8:455\u20138.","journal-title":"J. Drugs Dermatol"},{"key":"1701113_CR103","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/01.PRS.0000153823.52784.7E","volume":"115","author":"A Prado","year":"2005","unstructured":"Prado A, Andrades P, Benitez S, Umana M. (2005) Scar management after breast surgery: preliminary results of a prospective, randomized, and double-blind clinical study with aldara cream 5% (imiquimod). Plast. Reconstr. Surg. 115:966\u201372.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR104","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(09)60322-6","volume":"373","author":"MW Ferguson","year":"2009","unstructured":"Ferguson MW, et al. (2009) Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I\/II studies. Lancet. 373:1264\u201374.","journal-title":"Lancet"},{"key":"1701113_CR105","doi-asserted-by":"publisher","first-page":"690613","DOI":"10.1155\/2010\/690613","volume":"2010","author":"J Bush","year":"2010","unstructured":"Bush J, et al. (2010) Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring. Dermatol Res Pract 2010:690613.","journal-title":"Dermatol Res Pract"},{"key":"1701113_CR106","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1479-666X(07)80045-X","volume":"5","author":"M Jalali","year":"2007","unstructured":"Jalali M, Bayat A. (2007) Current use of steroids in management of abnormal raised skin scars. Surgeon. 5:175\u201380.","journal-title":"Surgeon"},{"key":"1701113_CR107","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00000637-199410000-00007","volume":"33","author":"NI Cruz","year":"1994","unstructured":"Cruz NI, Korchin L. (1994) Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann. Plast. Surg. 33:401\u20135.","journal-title":"Ann. Plast. Surg"},{"key":"1701113_CR108","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00005373-199502000-00030","volume":"38","author":"C Boyadjiev","year":"1995","unstructured":"Boyadjiev C, Popchristova E, Mazgalova J. (1995) Histomorphologic changes in keloids treated with Kenacort. J. Trauma. 38:299\u2013302.","journal-title":"J. Trauma"},{"key":"1701113_CR109","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clindermatol.2006.09.009","volume":"25","author":"DT Robles","year":"2007","unstructured":"Robles DT, Berg D. (2007) Abnormal wound healing: keloids. Clin. Dermatol. 25:26\u201332.","journal-title":"Clin. Dermatol"},{"key":"1701113_CR110","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/00000637-199108000-00012","volume":"27","author":"WT Lawrence","year":"1991","unstructured":"Lawrence WT. (1991) In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann. Plast. Surg. 27:164\u201378.","journal-title":"Ann. Plast. Surg"},{"key":"1701113_CR111","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1365-4632.2004.02570.x","volume":"44","author":"F Boutli-Kasapidou","year":"2005","unstructured":"Boutli-Kasapidou F, Tsakiri A, Anagnostou E, Mourellou O. (2005) Hypertrophic and keloidal scars: an approach to polytherapy. Int. J. Dermatol. 44:324\u20137.","journal-title":"Int. J. Dermatol"},{"issue":"Suppl","key":"1701113_CR112","first-page":"61","volume":"42","author":"E Jaros","year":"1999","unstructured":"Jaros E, Priborsky J, Klein L. (1999) Treatment of keloids and hypertrophic scars with cryotherapy [in Czech]. Acta Medica (Hradec Kralove). Suppl. 42:61\u20133.","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"1701113_CR113","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/095466301317085363","volume":"12","author":"G Yosipovitch","year":"2001","unstructured":"Yosipovitch G, et al. (2001) A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: a controlled study. J. Dermatolog. Treat. 12:87\u201390.","journal-title":"J. Dermatolog. Treat"},{"key":"1701113_CR114","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0272-7358(97)00056-1","volume":"17","author":"D Sharpe","year":"1997","unstructured":"Sharpe D. (1997) Of apples and oranges, file drawers and garbage: why validity issues in meta-analysis will not go away. Clin. Psychol. Rev. 17:881\u2013901.","journal-title":"Clin. Psychol. Rev"},{"key":"1701113_CR115","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1524-4725.1993.tb00386.x","volume":"19","author":"L Rusciani","year":"1993","unstructured":"Rusciani L, Rossi G, Bono R. (1993) Use of cryotherapy in the treatment of keloids. J. Dermatol. Surg. Oncol. 19:529\u201334.","journal-title":"J. Dermatol. Surg. Oncol"},{"key":"1701113_CR116","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/archderm.1993.01680300074011","volume":"129","author":"CC Zouboulis","year":"1993","unstructured":"Zouboulis CC, Blume U, Buttner P, Orfanos CE. (1993) Outcomes of cryosurgery in keloids and hypertrophic scars: a prospective consecutive trial of case series. Arch. Dermatol. 129:1146\u201351.","journal-title":"Arch. Dermatol"},{"key":"1701113_CR117","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/01.PRS.0000056868.42679.05","volume":"111","author":"Y Har-Shai","year":"2003","unstructured":"Har-Shai Y, Amar M, Sabo E. (2003) Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast. Reconstr. Surg. 111:1841\u201352.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR118","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/00001665-200309000-00009","volume":"14","author":"VN Poochareon","year":"2003","unstructured":"Poochareon VN, Berman B. (2003) New therapies for the management of keloids. J. Craniofac. Surg. 14:654\u20137.","journal-title":"J. Craniofac. Surg"},{"key":"1701113_CR119","first-page":"1835","volume":"49","author":"TJ Zuber","year":"1994","unstructured":"Zuber TJ, DeWitt DE. (1994) Earlobe keloids. Am. Fam. Physician. 49:1835\u201341.","journal-title":"Am. Fam. Physician"},{"key":"1701113_CR120","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0360-3016(00)01563-7","volume":"50","author":"B Guix","year":"2001","unstructured":"Guix B, et al. (2001) Treatment of keloids by high-dose-rate brachytherapy: a seven-year study. Int. J. Radiat. Oncol. Biol. Phys. 50:167\u201372.","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"1701113_CR121","first-page":"547","volume":"111","author":"R Ogawa","year":"2003","unstructured":"Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T. (2003) Postoperative electron-beam irradiation therapy for keloids and hyper-trophic scars: retrospective study of 147 cases followed for more than 18 months. Plast. Reconstr. Surg. 111:547\u201355.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR122","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/lsm.1900040309","volume":"4","author":"DB Apfelberg","year":"1984","unstructured":"Apfelberg DB, et al. (1984) Preliminary results of argon and carbon dioxide laser treatment of keloid scars. Lasers Surg. Med. 4:283\u201390.","journal-title":"Lasers Surg. Med"},{"key":"1701113_CR123","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/sder.2000.18369","volume":"19","author":"TS Alster","year":"2000","unstructured":"Alster TS, Handrick C. (2000) Laser treatment of hypertrophic scars, keloids, and striae. Semin. Cutan. Med. Surg. 19:287\u201392.","journal-title":"Semin. Cutan. Med. Surg"},{"key":"1701113_CR124","first-page":"4","volume":"9","author":"EL Tanzi","year":"2004","unstructured":"Tanzi EL, Alster TS. (2004) Laser treatment of scars. Skin Therapy Lett. 9:4\u20137.","journal-title":"Skin Therapy Lett"},{"key":"1701113_CR125","first-page":"25","volume":"29","author":"T Alster","year":"2003","unstructured":"Alster T. (2003) Laser scar revision: comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids. Dermatol. Surg. 29:25\u20139.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR126","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0140-6736(95)91989-9","volume":"345","author":"TS Alster","year":"1995","unstructured":"Alster TS, Williams CM. (1995) Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet. 345:1198\u2013200.","journal-title":"Lancet"},{"key":"1701113_CR127","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00006534-199501000-00012","volume":"95","author":"C Dierickx","year":"1995","unstructured":"Dierickx C, Goldman MP, Fitzpatrick RE. (1995) Laser treatment of erythematous\/hypertrophic and pigmented scars in 26 patients. Plast. Reconstr. Surg. 95:84\u201392.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR128","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/00042728-200406000-00019","volume":"30","author":"HH Chan","year":"2004","unstructured":"Chan HH, et al. (2004) The use of pulsed dye laser for the prevention and treatment of hyper-trophic scars in Chinese persons. Dermatol. Surg. 30:987\u201394.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR129","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1365-2133.1998.02127.x","volume":"138","author":"EJ Fiskerstrand","year":"1998","unstructured":"Fiskerstrand EJ, Svaasand LO, Volden G. (1998) Pigmentary changes after pulsed dye laser treatment in 125 northern European patients with port wine stains. Br. J. Dermatol. 138:477\u20139.","journal-title":"Br. J. Dermatol"},{"key":"1701113_CR130","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1034\/j.1600-0846.2001.70305.x","volume":"7","author":"JF Hermanns","year":"2001","unstructured":"Hermanns JF, Petit L, Hermanns-Le T, Pierard GE. (2001) Analytic quantification of phototype-related regional skin complexion. Skin. Res. Technol. 7:168\u201371.","journal-title":"Skin. Res. Technol"},{"key":"1701113_CR131","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1172\/JCI111480","volume":"74","author":"SA Jimenez","year":"1984","unstructured":"Jimenez SA, Freundlich B, Rosenbloom J. (1984) Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J. Clin. Invest. 74:1112\u20136.","journal-title":"J. Clin. Invest"},{"key":"1701113_CR132","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S0190-9622(89)70239-5","volume":"21","author":"B Berman","year":"1989","unstructured":"Berman B, Duncan MR. (1989) Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J. Am. Acad. Dermatol. 21:694\u2013702.","journal-title":"J. Am. Acad. Dermatol"},{"key":"1701113_CR133","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/00006534-199810000-00001","volume":"102","author":"EE Tredget","year":"1998","unstructured":"Tredget EE, et al. (1998) Transforming growth factor-beta in thermally injured patients with hyper-trophic scars: effects of interferon alpha-2b. Plast. Reconstr. Surg. 102:1317\u201328; discussion 1329\u201330.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR134","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/00006534-199810000-00001","volume":"102","author":"EE Tredget","year":"1998","unstructured":"Tredget EE, et al. (1998) Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast. Reconstr. Surg. 102:1317\u201330.","journal-title":"Plast. Reconstr. Surg"},{"key":"1701113_CR135","first-page":"23","volume":"27","author":"A Espana","year":"2001","unstructured":"Espana A, Solano T, Quintanilla E. (2001) Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol. Surg. 27:23\u20137.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR136","first-page":"791","volume":"123","author":"I Bodokh","year":"1996","unstructured":"Bodokh I, Brun P. (1996) Treatment of keloid with intralesional bleomycin [in French]. Ann. Dermatol. Venereol. 123:791\u20134.","journal-title":"Ann. Dermatol. Venereol"},{"key":"1701113_CR137","first-page":"1023","volume":"32","author":"FF Naeini","year":"2006","unstructured":"Naeini FF, Najafian J, Ahmadpour K. (2006) Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol. Surg. 32:1023\u201330.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR138","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1365-4632.2005.02633.x","volume":"44","author":"Y Saray","year":"2005","unstructured":"Saray Y, Gulec AT. (2005) Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int. J. Dermatol. 44:777\u201384.","journal-title":"Int. J. Dermatol"},{"key":"1701113_CR139","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1440-0960.2004.00072.x","volume":"45","author":"M Apikian","year":"2004","unstructured":"Apikian M, Goodman G. (2004) Intralesional 5-fluorouracil in the treatment of keloid scars. Australas. J. Dermatol. 45:140\u20133.","journal-title":"Australas. J. Dermatol"},{"key":"1701113_CR140","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1524-4725.1999.08165.x","volume":"25","author":"RE Fitzpatrick","year":"1999","unstructured":"Fitzpatrick RE. (1999) Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol. Surg. 25:224\u201332.","journal-title":"Dermatol. Surg"},{"key":"1701113_CR141","first-page":"54","volume":"30","author":"S Nanda","year":"2004","unstructured":"Nanda S, Reddy BS. (2004) Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol. Surg. 30:54\u20137.","journal-title":"Dermatol. Surg"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/molmed.2009.00153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2009.00153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T15:49:48Z","timestamp":1685893788000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2009.00153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,5]]},"references-count":141,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1701113"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2009.00153","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,5]]}}}